Enhanced CBT for Depression
Trial Summary
What is the purpose of this trial?
Depression in youth is a serious public health concern for which more personalized treatments are needed. This randomized controlled trial will test the effect of an intervention aimed at enhancing social cognitive capacities (e.g., ability to take another's perspective), thereby making treatment of depression in youth more efficient and effective. Participants in the R33 (N=82) will be youth between ages 13- through 17-years-old currently experiencing depression. Youth will be randomized to either an enhanced CBT intervention that teaches social cognitive skills, particularly social perspective taking and theory of mind (CBTSCT) as compared to CBT only. The primary target is improvement in both social cognitive skills and depressive symptoms at post-treatment and at a 6-month follow-up.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment CBTSCT for depression?
Is Enhanced CBT for Depression safe for humans?
The studies reviewed suggest that Cognitive Behavioral Therapy (CBT) and its variations, including those enhanced with social cognitive training, are generally safe for humans. Participants in these studies showed high attendance and completion rates, indicating that the treatment was well-tolerated.678910
How is the Enhanced CBT for Depression treatment different from other treatments for depression?
Enhanced CBT for Depression combines traditional cognitive behavioral therapy (CBT) with social cognitive training, which may offer additional benefits by focusing on improving social understanding and interactions, potentially addressing aspects of depression that standard CBT alone might not target.211121314
Eligibility Criteria
This trial is for young people aged 13-17 who are currently dealing with depression. They must have been diagnosed with a depressive disorder or score over 15 on the PHQ9 questionnaire. It's not open to those at immediate risk of suicide, below a 4th-grade reading level, struggling with severe substance abuse, or previously diagnosed with bipolar, schizophrenia, autism, or conduct disorder.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either CBT enhanced with social cognitive training or CBT only for 12 weeks
Follow-up
Participants are monitored for improvements in social cognitive skills and depressive symptoms
Treatment Details
Interventions
- CBTSCT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator